Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.2B | 3.2B | 3.2B | 3.2B |
Cost of revenue | 2.4B | 2.4B | 2.4B | 2.5B |
Gross profit | 768M | 809M | 814M | 710M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 127M | 335M | 353M | 301M |
Other operating expenses | — | — | — | — |
Operating income | 329M | 154M | 132M | 83M |
Non operating interest income | ||||
Income | 46M | 51M | 51M | 51M |
Expense | 58M | 66M | 69M | 72M |
Other income expense | 21M | -8M | -21M | 6M |
Pretax income | 338M | 131M | 93M | 68M |
Tax provision | 75M | 68M | 48M | 43M |
Net income | 263M | 63M | 45M | 25M |
Basic EPS | 1.5 | 0.3 | 0.2 | 0.1 |
Diluted EPS | 1.4 | 0.3 | 0.2 | 0.1 |
Basic average shares | 181.1M | 181.0M | 180.9M | 179.7M |
Diluted average shares | 184.8M | 184.8M | 183.9M | 182.9M |
EBITDA | 730M | 562M | 566M | 507M |
Net income from continuing op. | 263M | 63M | 45M | 25M |
Minority interests | 1M | -6M | -3M | 1M |
Preferred stock dividends | — | — | — | — |